Replies to post #199 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

RVNC adds ex-CEO of ZLTQ to BoD:

https://finance.yahoo.com/news/revance-appoints-mark-foley-board-113000252.html

Revance Therapeutics…today announced that Mark Foley has been appointed to Revance’s Board of Directors, effective September 5, 2017.

Mr. Foley most recently served as Chairman, President and CEO of ZELTIQ* Aesthetics (ZLTQ). He brings more than 25 years of operational and investment experience in the healthcare arena, and earlier this year led the sale of ZELTIQ to Allergan for $2.5 billion.